Ranbaxy Laboratories is trading higher by 3% at Rs 491, extending its 6% gain in past three trading days, after the pharmaceutical company said... ...
http://www.business-standard.com/india/news/ranbaxy-extends-gainresuming-drug-exports-to-us/162513/onRanbaxy Laboratories has started exports of its generic version of blockbuster cholesterol drug Lipitor from a new facility at its special economic... ...
http://www.dnaindia.com/money/report_ranbaxy-may-earn-a-third-less-from-lipitor_1670744After facing a four-year ban due to its regulatory issues, Ranbaxy Laboratories has now resumed exports of cholesterol-lowering drug, Atorvastatin... ...
http://timesofindia.feedsportal.com/fy/8at2Etb0Y6Bhz26p/story01.htmRanbaxy Laboratories, on Monday, said it had commenced exports of finished drugs to the U.S. market. ufffdufffdufffdThe first consignment of... ...
http://www.thehindu.com/business/article3273735.eceRanbaxy Laboratories today said it has resumed exports of finished drugs to the US. ...
http://financialexpress.com/news/after-4yr-hiatus-ranbaxy-exports-to-us/931587/